Cloud Banner

Pharmaceutical

Image

Global Anticoagulant Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Jan 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Anticoagulant Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR - 5.6% Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 60.90 Million
Diagram Market Size (Forecast Year) USD 94.17 Million
Diagram CAGR 5.6%

Global Anticoagulant Market, By Drug Class (Vitamin K Antagonist (Warfarin), Non-VKA Oral Anticoagulants (NOACS), Heparin and LMWH, Thrombin Inhibitors (Dabigatran)), Therapeutic Areas (Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Atrial Fibrillation, Heart Attack, Stroke, Unstable Angina, Hip Or Knee Replacement Surgery, Others), Route Of Administration (Oral, Parenteral), End User (Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers, Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2030.

Anticoagulant Market

 Anticoagulant Market Analysis and Size

According to the Centers for Disease Control and Prevention, men and women are equally affected by von Willebrand disease (VWD), which affects up to 1% of the general population. Between 2012 and 2016, over 14,600 men, women, and children were treated for von Willebrand disease (VWD) at haemophilia treatment centres; approximately two-thirds of these were women and girls. As a result, the global market is expected to be driven by an increase in cases of coagulation disorders during the forecast period.

Data Bridge Market Research analyses that the anticoagulant market which is USD 60.90 million in 2022, is expected to reach USD 94.17 million by 2030, at a CAGR of 5.6% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Anticoagulant Market Scope and Segmentation  

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Drug Class (Vitamin K Antagonist (Warfarin), Non-VKA Oral Anticoagulants (NOACS), Heparin and LMWH, Thrombin Inhibitors (Dabigatran)), Therapeutic Areas (Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Atrial Fibrillation, Heart Attack, Stroke, Unstable Angina, Hip Or Knee Replacement Surgery, Others), Route Of Administration (Oral, Parenteral), End User (Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers, Others), Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy, Others)

Countries Covered

Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Pfizer Inc (U.S.), AstraZeneca (U.K.), Bristol-Myers Squibb Company (U.S.), Dr. Reddy's Laboratories Ltd (India), Endo International plc (Ireland), Teva Pharmaceutical Industries Ltd (Israel), Sun Pharmaceutical Industries Ltd (India), Mylan N.V. (U.S.), Novartis AG (Switzerland), Lupin (India), Cipla Inc (India), Aurobindo Pharma (India), Sanofi (France), Merck & Co., Inc (U.S.), Amneal Pharmaceuticals LLC. (U.K.), Alvogen (U.S.), Bausch Health Companies Inc. (Canada)

Market Opportunities

  • Rising Use of Warfarin

Market Definition

Anticoagulants are medications that aid in the prevention of blood clots. They are given to people at high risk of clotting to lower their chances of developing serious conditions such as strokes and heart attacks. A blood clot is a seal formed by blood to stop bleeding from wounds. If a blood clot prevents blood from flowing through a vessel, the affected area of the body will be deprived of oxygen and may cease to function properly. Aspirin, heparin, and warfarin are examples of anticoagulants.

Anticoagulant Market Dynamics

Drivers

  • Increase in Elderly Population

People over the age of 65 are the world's fastest growing demographic segment, according to the World Health Organization (WHO). The proportion of the world's population over the age of 60 is expected to double between 2000 and 2050, rising from about 11% to 22%. According to the CDC, approximately 2% of people under the age of 65 have atrial fibrillation, while 9% of people over the age of 65 have the disease. It is also predicted that by 2030, nearly 12.1 million people will have atrial fibrillation. As a result, during the forecast period, the growing elderly population will drive the global anticoagulant reversal drugs market growth.

  • Increase in Hip and Knee Surgeries 

The rising number of knee and hip replacement surgeries increases the likelihood of developing deep vein thrombosis (DVT). Surgery frequently results in prolonged immobility, which increases the risk of DVT due to decreased blood flow in the body. The number of surgical procedures performed on the elderly population has increased, according to the WHO 2016 report. The increased number of surgeries is expected to increase the likelihood of thromboembolic events following surgery, increasing patient demand for anticoagulant treatment.

Opportunities

  • Rising Use of Warfarin

Some medications, such as blood thinners such as warfarin, heparin, and aspirin, can cause bleeding disorders. The anticoagulant agent used influences the high risk of bleeding. According to the National Center for Biotechnology Information (NCBI), bleeding in warfarin patients is estimated to be 15-20% each year. Warfarin-related life-threatening bleeding is expected to occur at a rate of 1-3% per year. As a result of the increased demand for anticoagulant therapies, potential opportunities for anticoagulant reversal agents are emerging.

Restraints/Challenges

  • Side Effects of Medicines

Some medications can have a negative impact on the health of the population, particularly the elderly. It can sometimes cause excessive bleeding, and the higher dosage can cause a slew of complications. As a result, drug side effects limit the growth of the global anticoagulant reversal drugs market.

This anticoagulant market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the anticoagulant market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

  • In 2019, Bristol-Myers Squibb-Pfizer Alliance received safety and efficacy data for Eliquis for the treatment of venous thromboembolism in cancer patients. This efficacy data aided the company in providing physicians and patients with more opportunities to treat venous thromboembolism, resulting in increased product sales.
  • In 2019, Cipla Inc. signed a partnership agreement with Wellthy Therapeutics Private Limited to provide digital therapeutics to cardiovascular disease patients. Because the company provides anticoagulants for the treatment of cardiovascular disease, this collaboration assisted the company in improving its platform for anticoagulant drugs by providing all anticoagulant therapy-related information through a digital platform.

Global Anticoagulant Market Scope

The anticoagulant market is segmented on the basis of drug class, therapeutic areas, route of administration, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Class

  • Vitamin K Antagonist (Warfarin)
  • Non-VKA Oral Anticoagulants (NOACS)
  • Eliquis
  • Bevyxxa
  • Xarelto
  • Savaysa and lixiana
  • pradaxa
  • Heparin and LMWH
  • Thrombin Inhibitors (Dabigatran)

 Therapeutic Areas

  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Atrial Fibrillation
  • Heart Attack, Stroke
  • Unstable Angina
  • Hip or Knee Replacement Surgery
  • Others

 Route of Administration

  • Oral
  • Parenteral

 End User

  • Hospitals
  • Clinics
  • Home Healthcare
  • Ambulatory Surgical Centers
  • Others

 Distribution Channel

  • Hospitals Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Anticoagulant Market Regional Analysis/Insights

The anticoagulant market is analyzed and market size insights and trends are provided by country, drug class, therapeutic areas, route of administration, end user and distribution channel as referenced above.

The countries covered in the anticoagulant market report are Brazil, Argentina and Rest of South America as part of South America.

North America dominates the anticoagulant market because of the well-developed healthcare infrastructure and favourable reimbursement policies in the region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the growing incidence of cancer such as bladder, esophagus, liver, pancreas, and others, high presence of major manufacturers across the U.S. Furthermore, technological advancements and rising foreign investment.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The anticoagulant market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for anticoagulant market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the anticoagulant market. The data is available for historic period 2011-2021.

Competitive Landscape and Anticoagulant Market Share Analysis

The anticoagulant market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to anticoagulant market.

Some of the major players operating in the anticoagulant market are:

  • Pfizer Inc (U.S.)
  • AstraZeneca (U.K.)
  • Bristol-Myers Squibb Company (U.S.)
  • Dr. Reddy's Laboratories Ltd (India)
  • Endo International plc (Ireland)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Sun Pharmaceutical Industries Ltd (India)
  • Mylan N.V. (U.S.)
  • Novartis AG (Switzerland)
  • Lupin (India)
  • Cipla Inc (India)
  • Aurobindo Pharma (India)
  • Sanofi (France)
  • Merck & Co., Inc (U.S.)
  • Amneal Pharmaceuticals LLC. (U.K.)
  • Alvogen (U.S.)
  • Bausch Health Companies Inc. (Canada)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The anticoagulant market value was USD 60.90 million in 2022.
The anticoagulant market is projected to grow at a CAGR of 5.6% during the forecast period of 2023-2030.
The Anticoagulant Market report is bifurcated by drug class, therapeutic areas, route of administration, end-user, and distribution channel.
North America dominates the anticoagulant market because of the well-developed healthcare infrastructure and favorable reimbursement policies in the region.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials